AMPD1: A Novel Therapeutic Target for Reversing Insulin Resistance
BMC Endocrine Disorders - United Kingdom
doi 10.1186/1472-6823-14-96
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2014
Authors
Publisher
Springer Science and Business Media LLC